Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12858850rdf:typepubmed:Citationlld:pubmed
pubmed-article:12858850lifeskim:mentionsumls-concept:C0019158lld:lifeskim
pubmed-article:12858850lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12858850lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:12858850lifeskim:mentionsumls-concept:C0400447lld:lifeskim
pubmed-article:12858850lifeskim:mentionsumls-concept:C0279030lld:lifeskim
pubmed-article:12858850lifeskim:mentionsumls-concept:C1623038lld:lifeskim
pubmed-article:12858850lifeskim:mentionsumls-concept:C1880198lld:lifeskim
pubmed-article:12858850pubmed:issue6lld:pubmed
pubmed-article:12858850pubmed:dateCreated2003-7-14lld:pubmed
pubmed-article:12858850pubmed:abstractTextA patient with hepatitis C virus (HCV)-related liver cirrhosis and hepatocellular carcinoma (HCC) was treated successfully with an orthotopic liver transplantation (OLT) followed by interferon therapy. The 36-year-old Japanese man was diagnosed as having liver cirrhosis in 1983. HCC was detected in 1991, and by 1994, jaundice and ascites had developed. The patient underwent OLT in June 1995, after which hepatitis C recurred, with elevated aminotransferases. His liver biopsy specimen showed chronic active hepatitis. He was given interferon-alpha three times weekly for 24 weeks in 1999. Six months after the end of the interferon treatment, the patient's serum HCV RNA became negative, with normalization of aminotransferases, and his liver histology exhibited amelioration of fibrosis and inflammation. At the present time, he remains free of HCC (more than 6.5 years after the OLT) and free of HCV RNA (more than 2.5 years since interferon therapy was completed). This is the first Japanese patient whose HCC was cured by OLT and HCV was eradicated by interferon therapy.lld:pubmed
pubmed-article:12858850pubmed:languageenglld:pubmed
pubmed-article:12858850pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12858850pubmed:citationSubsetIMlld:pubmed
pubmed-article:12858850pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12858850pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12858850pubmed:statusMEDLINElld:pubmed
pubmed-article:12858850pubmed:issn0944-1174lld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:MitamuraKeiji...lld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:YanagaKatsuhi...lld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:MorizaneToshi...lld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:EsquivelCarlo...lld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:ShibataMinoru...lld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:UenoYukihisaYlld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:YanagawaTatsu...lld:pubmed
pubmed-article:12858850pubmed:authorpubmed-author:HirakawaMasam...lld:pubmed
pubmed-article:12858850pubmed:issnTypePrintlld:pubmed
pubmed-article:12858850pubmed:volume38lld:pubmed
pubmed-article:12858850pubmed:ownerNLMlld:pubmed
pubmed-article:12858850pubmed:authorsCompleteYlld:pubmed
pubmed-article:12858850pubmed:pagination598-602lld:pubmed
pubmed-article:12858850pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:meshHeadingpubmed-meshheading:12858850...lld:pubmed
pubmed-article:12858850pubmed:year2003lld:pubmed
pubmed-article:12858850pubmed:articleTitleA patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.lld:pubmed
pubmed-article:12858850pubmed:affiliationDepartment of Gastroenterology, Kanto Medical Center NTT EC, Tokyo, Japan.lld:pubmed
pubmed-article:12858850pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12858850pubmed:publicationTypeReviewlld:pubmed
pubmed-article:12858850pubmed:publicationTypeCase Reportslld:pubmed